Welcome to AD/PD™ on UNLOK!
The eLearning Portal of the AD/PD™ Conference, full of online courses, webinars, Conference videos, research papers, and so much more!
This platform is your gateway to a treasure trove of valuable information and resources, meticulously curated to empower Health Care Professionals specializing in neurodegenerative diseases.
Engage, Share, and Collaborate
Are you interested in sharing your latest research findings or case studies with an attentive audience of colleagues? Would you like to lead a discussion or give an analysis of an interesting new or controversial topic? This is your chance!
COURSES
α-syn pathology in the periphery: A window into early diagnosis
This session convened distinguished scholars Prof. Per Borghammer, Prof. Beomseok Jeon, Prof. Tiago Outeiro, and Prof. Erwan Bezard to delve into the intricacies and challenges surrounding the diagnosis and understanding of Parkinson's Disease (PD).
Evaluating Donanemab's Efficacy and its Role in Alzheimer's Disease Treatment
This session brought together esteemed experts Curtis P. Schrieber, MD, Giacomo Koch, MD, PhD and Miranda E. Orr, PhD to explore the implications of these findings for future research and the potential impact on patient outcomes.
Meet the Expert interviews
At AD/PD™ 2023, we connected with leading experts like Dr. Marc Diamond, Prof. Li-Huei Tsai, and Dr. Melissa Murray. These discussions offered valuable insights into their careers and the future of Alzheimer's and Parkinson's diseases' researchers.
Entering the Era of Disease-Modifying Treatments for AD
This symposium discussed how the efficacy of anti-amyloid beta (Aβ) monoclonal antibodies (mAbs) was evaluated in clinical trials (both for therapeutic and preventive treatment of Alzheimer’s disease) versus in real-world clinical practice and explored how clinically meaningful outcomes for patients living with AD may be defined in today’s clinical practice.
Detecting Brain Amyloid Burden with PET
GE Healthcare brings its 4 module e-learning certification course on detecting brain amyloid burden with PET. In this module, learn about the evolution of MCI and AD diagnosis and the role of biomarkers. This course is open to healthcare professionals who are based in Europe.
EXCLUSIVE CONTENT
UPCOMING EVENTS
AD/PD™ February Journal Club!
Join us for the first AD/PD™ Live Journal Club of 2025, discussing the Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer’s Disease.
Joint AD/PD™ and The Mosaic of Autoimmunity Webinar
Mark your calendars for the first ever joint AD/PD™ and The Mosaic of Autoimmunity webinar – “Crossing Boundaries: Exploring Polyamine Dysregulation in Alzheimer’s and Autoimmune Disorders”!
EVENT RECORDINGS
AD/PD™ November Journal Club!
Watch the recording of this Journal Club, where we'll explored Classification of Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) Using Manual Motor Measures—a study that could reshape the future of neurodegenerative disease diagnosis.
AD/PD™ October Journal Club
The article explores the relationship between amyloid-β (Aβ) deposits in the brain and real-world cognitive tasks, particularly grocery shopping, in older adults who do not have cognitive impairments.
AD/PD™ October Webinar
Join us for an insightful webinar discussing the Novelties in the early detection, treatment and lifestyle interventions for Alzheimer’s disease. This session will bring together esteemed experts: Dr. Suzanne Hendrix, Dr. Galvin James, Prof. Dr. Philip Scheltens and Dr. M.L.F. Ruitenberg.
Watch the AD/PD™2023 Conference Recordings
Did you miss the AD/PD™23 Conference last year? You can now view more than 100 hours of content in the AD/PD™ Education Portal!
AD/PD™2024 - CME/CPD Certificate & Conference Recordings
Here's how to claim your CME/CPD Certificate after the AD/PD 2024 Conference.